Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Nov 16, 2020	MURPHY ANDREW J EVP Research Trans History: 222	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	7,108	$561.39	53,764
May 21, 2020	VAGELOS P ROY Director, Chairman of the Board Trans History: 742	Director, Chairman of the Board	Form 4	Open market or private sale of non-derivative or derivative security	10,418	$561.40	407,397
Oct 01, 2020	RYAN ARTHUR F Director Trans History: 524	Director	Form 4	Open market or private sale of non-derivative or derivative security	4	$561.48	28,358
May 07, 2020	Van Plew Daniel P EVP & General Mgr Industrial O Trans History: 359	EVP & General Mgr Industrial O	Form 4	Open market or private sale of non-derivative or derivative security	4,988	$561.55	56,297
Apr 20, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Open market or private sale of non-derivative or derivative security	51	$561.57	19,687
Nov 02, 2015	YANCOPOULOS GEORGE Director, President Regeneron Laboratori Trans History: 628	Director, President Regeneron Laboratori	Form 4	Open market or private sale of non-derivative or derivative security	1,200	$561.75	585,496
Apr 17, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Open market or private sale of non-derivative or derivative security	63	$561.76	14,987
Jul 01, 2021	RYAN ARTHUR F Director Trans History: 524	Director	Form 4	Open market or private sale of non-derivative or derivative security	6	$561.80	23,574
Apr 17, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Open market or private sale of non-derivative or derivative security	92	$561.96	24,516
May 07, 2020	BROWN MICHAEL S Director Trans History: 466	Director	Form 4	Open market or private sale of non-derivative or derivative security	1,809	$562.00	643

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media